Fortress Biotech
FBIO
42 hedge funds and large institutions have $14.1M invested in Fortress Biotech in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 18 closing their positions.
96% more capital invested
Capital invested by funds: $7.2M → $14.1M (+$6.9M)
74% more call options, than puts
Call options by funds: $174K | Put options by funds: $100K
30.48% more ownership
Funds ownership: 1.13% → 31.61% (+30%)
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
13% less funds holding
Funds holding: 48 → 42 (-6)
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$2.02M |
| 2 |
AC
Armistice Capital
New York
|
+$1.58M |
| 3 |
ACM
Altium Capital Management
New York
|
+$1.07M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$865K |
| 5 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$348K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$581K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$408K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$75.8K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$26.7K |
| 5 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$21.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| – | -$6.6K | -1,517 | Closed |
|
52
Creative Planning
Overland Park,
Kansas
| – | -$4.62K | -1,060 | Closed |
|
|
BMCM
53
Black Maple Capital Management
Milwaukee,
Wisconsin
| – | -$4.36K | -1,000 | Closed |
|
|
TDC
54
Thompson Davis & Co
Richmond,
Virginia
| – | -$3.77K | -866 | Closed |
|
|
HF
55
HRT Financial
New York
| – | -$3K | -804 | Closed |
|
|
WP
56
WMS Partners
Towson,
Maryland
| – | -$3.38K | -775 | Closed |
|
|
DAM
57
Delta Asset Management
Memphis,
Tennessee
| – | -$1.74K | -400 | Closed |
|
58
BNP Paribas Financial Markets
Paris,
France
| – | -$1.64K | -377 | Closed |
|
|
CG
59
Cutler Group
San Francisco,
California
| – | -$1K | -267 | Closed |
|
|
LC
60
Lindbrook Capital
Calabasas,
California
| – | -$8 | -2 | Closed |
|
FBIO Hedge Fund Activity: Q4 2023 in Review
42 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2023, worth a combined $14.1M — up 96% from $7.2M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FBIO and 12 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 14 added.
The largest buyer was CVI Holdings, opening a new position worth an estimated $2.02M. The largest seller was Opaleye Management, exiting entirely with an estimated $581K sold.
- 42 institutional investors held Fortress Biotech (FBIO) as of Q4 2023, down from 48 in Q3 2023.
- Funds reported $14.1M of Fortress Biotech stock for Q4 2023, up 96% quarter-over-quarter.
- 12 funds opened new Fortress Biotech positions in Q4 2023 and 18 closed out, a net change of -6 holders.
- The largest Fortress Biotech buyer in Q4 2023 was CVI Holdings, an estimated $2.02M added.
- The largest Fortress Biotech seller in Q4 2023 was Opaleye Management, an estimated $581K sold.
Based on aggregated 13F filings for Q4 2023.